ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3208

Spinal Radiographic Progression in Early Axial Spondyloarthritis: Data from the DESIR Cohort

Sofia Ramiro1, Désirée van der Heijde1, Rosaline van den Berg2, Victoria Navarro-Compán3, Antoine Feydy4, Maria-Antonietta d'Agostino5, Damien Loeuille6, Maxime Dougados7, Monique Reijnierse8 and Pascal Claudepierre9, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Rheumatology, University Hospital La Paz, Madrid, Spain, 4Paris Descartes University, Radiology B department, Cochin Hospital, Paris, France, 5Rheumatology, Versailles-Saint Quentin en Yvelines University, Boulogne-Billancourt, France, 6Rheumatology, Nancy University Hospital, Nancy, France, 7Rheumatology Department, Cochin hospital, Paris-Descartes University, Paris, France, 8Radiology, Leiden University Medical Center, Leiden, Netherlands, 9Rheumatology, Université Paris Est Créteil, Créteil, France

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Outcome measures, radiography and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment: Clinical Aspects, Imaging and Biomarkers

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: The development of radiographic damage over time has been investigated in patients with AS, but not yet in early axial spondyloarthritis (axSpA). We have recently shown that the modified Stoke in Ankylosing Spondylitis Spine Score (mSASSS) is the most sensitive and adequate scoring method in (early) axSpA. Our aim was to analyse the development and progression of radiographic damage in the spine in patients with IBP and early axSpA.

Methods: Patients with IBP for <3 years and with a clinical suspicion for axSpA were included in DESIR. Yearly cervical and lumbar radiographs from the first 2 years of follow-up were used in this analysis. Patients with radiographs available allowing the estimation of at least one (1-year or 2-year) progression interval were included in this analysis. Two trained readers independently scored the radiographs according to the mSASSS (0-72). Scores per vertebral corner were averaged between the readers. One-year (M0-M12) and two-year (M0-M24) progression scores were computed. Progression was assessed in each of the different subgroups of patients defined at baseline according to the fulfillment of the ASAS axSpA criteria, imaging arm (modified New York Criteria (mNYC) +/- and MRI positivity (according to the ASAS definition)), clinical arm only (+/- positive CRP). In addition, patients were grouped according to presence of baseline syndesmophytes.

Results: In total, 608 patients (mean age 36.0 (SD 8.8) years, 47% males, 74% fulfilling ASAS axSpA criteria) were included. At baseline, the average mSASSS was 0.36 (1.49). From these patients, 571 one-year mSASSS progression intervals could be obtained and 441 two-year progression intervals. Patients fulfilling the ASAS axSpA criteria had on average 0.29 (1.73) mSASSS-units progression in 2 years, whereas those not fulfilling the criteria showed a progression of 0.06 (1.00) units. Patients fulfilling the imaging arm had a progression of 0.42 (2.21) mSASSS-units per 2 years. Within this subgroup of patients, patients fulfilling the mNYC and with a negative MRI had the highest progression, followed by those mNYC+ and MRI+ and lastly those mNYC- but with MRI+ (Table). Patients fulfilling only the clinical arm of the ASAS criteria had a progression of 0.11 (0.60) mSASSS-units per 2 years. Patients with baseline syndesmophytes (across all subgroups) had a 2-year progression of 1.16 (4.31) mSASSS-units.

Table – Progression of spinal radiographic damage over 2 years (1-year and 2-year intervals)

 

Subgroup

1-year mSASSS progression

(M0-M12)

n=517

mean (SD)

 

2-year mSASSS progression

(M0-M24)

n=441

mean (SD)

ASAS criteria

ASAS +

0.11 (1.15), n=366

0.29 (1.73), n=322

ASAS –

0.08 (0.69), n=147

0.06 (1.00), n=116

ASAS criteria Imaging arm

MRI+ mNYC+

0.20 (2.11), n=96

0.36 (2.38), n=88

MRI+ mNYC-

-0.02 (0.26), n=76

0.18 (0.93), n=63

MRI- mNYC+

0.17 (0.47), n=41

1.02 (3.21), n=34

ASAS criteria Clinical arm

Clinical arm only CRP+

0.05 (0.22), n=20

0.14 (0.50), n=21

Clinical arm only CRP-

0.10 (0.59), n=130

0.10 (0.62), n=112

Baseline syndesmophytes

Baseline syndesmophytes +

0.38 (3.15), n=34

1.16 (4.31), n=30

Baseline syndesmophytes –

0.08 (0.68), n=483

0.16 (1.12), n=411

Conclusion: Development of spinal radiographic progression can be captured in a cohort of patients with early axSpA within a 2-year follow-up. Progression is higher in patients fulfilling the mNYC and also in patients with baseline syndesmophytes.


Disclosure: S. Ramiro, None; D. van der Heijde, None; R. van den Berg, None; V. Navarro-Compán, None; A. Feydy, None; M. A. d'Agostino, None; D. Loeuille, None; M. Dougados, None; M. Reijnierse, None; P. Claudepierre, None.

To cite this abstract in AMA style:

Ramiro S, van der Heijde D, van den Berg R, Navarro-Compán V, Feydy A, d'Agostino MA, Loeuille D, Dougados M, Reijnierse M, Claudepierre P. Spinal Radiographic Progression in Early Axial Spondyloarthritis: Data from the DESIR Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/spinal-radiographic-progression-in-early-axial-spondyloarthritis-data-from-the-desir-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spinal-radiographic-progression-in-early-axial-spondyloarthritis-data-from-the-desir-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology